Skip to content

Medline

US · MDLN #667 by market cap Listed 2025
37.04 -0.80 -2.11%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Quant vs Street three independent views, side by side

StockVane factor grade
B-
Momentum strategy signal
Sell
Analyst consensus
Buy

Mostly aligned, one view stands apart.

Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.

Analyst consensus 17 analysts

Buy
Avg price target 47.64 +28.6%
Price target rangecurrent 37.04
Low44.00
Avg47.64
High55.00
Buy 100% Hold 0% Sell 0%
Recent ratings (25)
DateFirmAnalystRatingTarget
2026-11-20 Barclays -- Buy 45.00
2026-11-13 Tigress Financial -- Buy 55.00
2026-11-12 J.P. Morgan -- Buy 47.00
2026-11-11 RBC Capital -- Buy 46.00
2026-11-09 BofA Securities -- Buy --
2026-11-05 Bernstein -- Buy 49.00
2026-11-05 UBS -- Buy 49.00
2026-11-05 Baird -- Buy 44.00
2026-11-05 Morgan Stanley -- Buy 48.00
2026-11-05 Evercore -- Buy 44.00
2026-11-05 BMO Capital -- Buy 47.00
2026-11-05 Citi -- Buy 47.00
2026-11-05 Leerink Partners -- Buy 46.00
2026-11-04 Barclays -- Buy 43.00
2026-11-04 RBC Capital -- Buy 46.00
2026-10-22 Mizuho Securities -- Buy 45.00
2026-10-09 Barclays -- Buy 43.00
2026-10-07 Leerink Partners -- Buy 43.00
2026-10-06 RBC Capital -- Buy 46.00
2026-09-25 UBS -- Buy 43.00
2026-09-23 William Blair -- Buy --
2026-09-22 Truist Financial -- Buy --
2026-09-16 Leerink Partners -- Buy 43.00
2026-09-10 Leerink Partners -- Buy 34.05
2026-08-27 BTIG -- Buy 55.00

Price target trend monthly average, last 3 years

Earnings history price reaction on the day

PeriodReport dateSessionOptions expectedActual move
2026/Q3 2026-11-04 -- ±9.29% +18.36% (beat)
2026/Q2 2026-08-05 -- ±11.24% -12.79% (beat)
2026/Q1 2026-05-06 -- ±8.24% -7.30% (in line)
2025/Q4 2026-02-25 -- ±9.54% -3.62% (in line)

"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.

Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.

Medline discussion 0 comments

Add a comment